Bone Morphogenetic Protein 6 Inhibits the Immunomodulatory Property of BMMSCs via Id1 in Sjögren's Syndrome
Mesenchymal stem cells (MSCs) treatment has emerged as a promising approach for treating Sjögren's syndrome (SS). Impaired immunoregulatory activities of bone marrow mesenchymal stem cells (BMMSCs) are found in both SS patients and animal models, and the underlying mechanism is poorly understo...
Salvato in:
Autori principali: | Yingying Su (Autore), Yi Gu (Autore), Ruiqing Wu (Autore), Hao Wang (Autore) |
---|---|
Natura: | Libro |
Pubblicazione: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Bone morphogenetic proteins: The anomalous molecules
di: Aena Pundir Jain, et al.
Pubblicazione: (2013) -
Insights into bone morphogenetic proteins in cardiovascular diseases
di: Di Ye, et al.
Pubblicazione: (2023) -
Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish
di: Jelmer Hoeksma, et al.
Pubblicazione: (2020) -
Bone morphogenetic proteins: Signaling periodontal bone regeneration and repair
di: G Sai Anusuya, et al.
Pubblicazione: (2016) -
Inhibition of Osteoclast Generation: A Novel Function of the Bone Morphogenetic Protein 7/Osteogenic Protein 1
di: Thomas Maurer, et al.
Pubblicazione: (2012)